fexofenadine has been researched along with Kidney Failure, Chronic in 3 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fexofenadine clearance was not affected by time after dialysis (P = 0." | 1.56 | Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease. ( Åsberg, A; Christensen, H; Egeland, EJ; Robertsen, I; Witczak, BJ; Zaré, HK, 2020) |
| "ESRD can affect the pharmacokinetic disposition of drugs subject to nonrenal clearance." | 1.35 | ESRD impairs nonrenal clearance of fexofenadine but not midazolam. ( Frye, RF; Himmelfarb, J; Le, P; Leblond, FA; Naud, J; Nolin, TD; Pichette, V; Sadr, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Egeland, EJ | 1 |
| Witczak, BJ | 1 |
| Zaré, HK | 1 |
| Christensen, H | 1 |
| Åsberg, A | 1 |
| Robertsen, I | 1 |
| Nolin, TD | 1 |
| Frye, RF | 1 |
| Le, P | 1 |
| Sadr, H | 1 |
| Naud, J | 1 |
| Leblond, FA | 1 |
| Pichette, V | 1 |
| Himmelfarb, J | 1 |
| Wong, J | 1 |
| Phelps, R | 1 |
| Levitt, J | 1 |
3 other studies available for fexofenadine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease.
Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Drug Interact | 2020 |
ESRD impairs nonrenal clearance of fexofenadine but not midazolam.
Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Urea Nitrogen; | 2009 |
Treatment of acquired perforating dermatosis with cantharidin.
Topics: Aged; Anti-Allergic Agents; Cantharidin; Dermatologic Agents; Drug Therapy, Combination; Female; Hum | 2012 |